Washington Center for Bleeding Disorders is a clinical research site located in Seattle, Washington, United States 98101.
Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.
Washington Center for Bleeding Disorders has participated in 7 clinical trials with 7 currently active.
Therapeutic areas: Von Willebrand Disease (VWD), Von Willebrand Disease, Type 3, Concomitant VWD and Hemophilia.
Sponsors: Vega Therapeutics, Inc, Bleeding and Clotting Disorders Institute Peoria, Illinois, University of Washington.
Trust Score: 74/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Washington Center for Bleeding Disorders has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Washington Center for Bleeding Disorders has 7 clinical trials on record, with 7 currently active. Their work covers Von Willebrand Disease (VWD), Von Willebrand Disease, Type 3, Concomitant VWD and Hemophilia.
Yes — Washington Center for Bleeding Disorders holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.